Wauwatosa-based GenoPalate, Inc., a nutritional genomics company, has raised $5.6 million during the initial phase of its $10.6 million equity financing round. The funding will be used to expand the company’s product offerings.
The funding will also be used to improve the company’s mobile and web-based app and nutritional health data platform. These improvements will provide more contextualized, data-driven functionality for customers. It will also continue to support the development of unique research databases for addressing personalized nutrition, health and wellness, and chronic metabolic diseases such as type-2 diabetes, obesity, and metabolic syndrome.
Zang founded GenoPalate in 2016. Using proprietary algorithms, GenoPalate interprets each customer’s DNA and develops a personalized nutrition analysis that provides them with a list of over 100 foods that are most beneficial to their health. It also reveals their genetic-based needs for 23 different nutrients, sensitivities to lactose and gluten, how their DNA impacts mood and stress levels, and how fast their body processes alcohol and caffeine.